Related references
Note: Only part of the references are listed.N-acetylcysteine inhibits thrombosis in a murine model of myeloproliferative neoplasm
Brianna M. Craver et al.
BLOOD ADVANCES (2020)
Chronic myelogenous leukemia, a still unsolved problem: pitfalls and new therapeutic possibilities
Sylwia Flis et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
PI3K/Akt/mTOR signaling pathway participates in Streptococcus uberis-induced inflammation in mammary epithelial cells in concert with the classical TLRs/NF-κB pathway
Bin Li et al.
VETERINARY MICROBIOLOGY (2018)
Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses
Jerome Bourgeais et al.
ONCOTARGET (2017)
Thioredoxin-1 maintains mechanistic target of rapamycin (mTOR) function during oxidative stress in cardiomyocytes
Shin-ichi Oka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms
Mads Emil Bjorn et al.
MEDIATORS OF INFLAMMATION (2015)
Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway
Vladan P. Cokic et al.
PLOS ONE (2015)
STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia
Wolfgang Warsch et al.
Oncotarget (2015)
Inducible Nitric Oxide Synthase Drives mTOR Pathway Activation and Proliferation of Human Melanoma by Reversible Nitrosylation of TSC2
Esther Lopez-Rivera et al.
CANCER RESEARCH (2014)
ROS Function in Redox Signaling and Oxidative Stress
Michael Schieber et al.
CURRENT BIOLOGY (2014)
Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters
Jayne Loughery et al.
NUCLEIC ACIDS RESEARCH (2014)
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms
Niccolo Bartalucci et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2013)
A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
C. Marty et al.
LEUKEMIA (2013)
Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?
Hans Carl Hasselbalch
LEUKEMIA RESEARCH (2013)
NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma
Braden C. McFarland et al.
PLOS ONE (2013)
Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence
Tongyuan Li et al.
CELL (2012)
IL-6 Controls Leukemic Multipotent Progenitor Cell Fate and Contributes to Chronic Myelogenous Leukemia Development
Damien Reynaud et al.
CANCER CELL (2011)
Redox Regulates Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity by Modulating the TSC1/TSC2-Rheb GTPase Pathway
Sei Yoshida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Nitric oxide and redox mechanisms in the immune response
David A. Wink et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
The nuclear factor-kappa B-interleukin-6 signalling pathway mediating vascular inflammation
Allan R. Brasier
CARDIOVASCULAR RESEARCH (2010)
Mammalian target of rapamycin activity is required for expansion of CD34+ hematopoietic progenitor cells
Christian R. Geest et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Mechanisms of ROS modulated cell survival during carcinogenesis
J. S. Clerkin et al.
CANCER LETTERS (2008)
Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-Binding domain during oxidative stress
Chinavenmeni S. Velu et al.
BIOCHEMISTRY (2007)
Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function
Lea Fialkow et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Free radicals and antioxidants in normal physiological functions and human disease
Marian Valko et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
The antioxidant function of the p53 tumor suppressor
AA Sablina et al.
NATURE MEDICINE (2005)
Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex
DD Sarbassov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
An expanding role for mTOR in cancer
DA Guertin et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Signaling by target of rapamycin proteins in cell growth control
K Inoki et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2005)
Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species
JH Kim et al.
BLOOD (2005)
Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages
L Williams et al.
JOURNAL OF IMMUNOLOGY (2004)
Redox regulation of PI 3-kinase signalling via inactivation of PTEN
NR Leslie et al.
EMBO JOURNAL (2003)
Autoinhibition of Bcr-Abl through its SH3 domain
KM Smith et al.
MOLECULAR CELL (2003)
Oxidant signals and oxidative stress
T Finkel
CURRENT OPINION IN CELL BIOLOGY (2003)
Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells
M Huang et al.
ONCOGENE (2002)
Share Paper
